|
SLC36A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.557250E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.243000E-01 |
| Normal-vs-Stage2 |
7.478600E-01 |
| Normal-vs-Stage3 |
1.766600E-01 |
| Normal-vs-Stage4 |
1.018360E-01 |
| Stage1-vs-Stage2 |
5.722000E-01 |
| Stage1-vs-Stage3 |
4.691600E-01 |
| Stage1-vs-Stage4 |
2.366200E-01 |
| Stage2-vs-Stage3 |
3.116600E-01 |
| Stage2-vs-Stage4 |
2.013000E-01 |
| Stage3-vs-Stage4 |
7.977400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.085190E-01 |
| Normal-vs-AfricanAmerican |
2.207200E-01 |
| Normal-vs-Asian |
8.292300E-02 |
| Caucasian-vs-AfricanAmerican |
5.099000E-01 |
| Caucasian-vs-Asian |
5.155200E-01 |
| AfricanAmerican-vs-Asian |
7.702800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.232200E-01 |
| Normal-vs-Female |
1.096840E-01 |
| Male-vs-Female |
3.681800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.229210E-01 |
| Normal-vs-Age(41-60Yrs) |
3.960400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.054800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.643000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.205600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.192000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.625800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.016000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.844000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.257200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.317800E-01 |
| Classical-VS-Follicular |
5.60349999999543E-05 |
| Classical-VS-Other |
1.216050E-01 |
| Classical-VS-Normal |
2.189700E-02 |
| Tall-VS-Follicular |
1.898110E-02 |
| Tall-VS-Other |
1.283630E-01 |
| Tall-VS-Normal |
9.969900E-02 |
| Follicular-VS-Other |
6.495600E-01 |
| Follicular-VS-Normal |
2.389400E-01 |
| Other-VS-Normal |
2.849600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.423600E-01 |
| Normal-vs-N1 |
6.218200E-01 |
| N0-vs-N1 |
7.614600E-01 |
|
|
